Autonomic Nervous System Drugs Practice Questions

Q: What is the mechanism of action of dantrolene?

Binds to ryanodine receptors to block the release of Ca++. **Explanation:** **Mechanism of Action:** Dantrolene is a direct-acting skeletal muscle relaxant. Its primary mechanism involves binding to the **Ryanodine Receptor 1 (RyR1)** located on the membrane of the **sarcoplasmic reticulum** (SR) in skeletal muscle cells [1]. By antagonizing these receptors, dantrolene inhibits the release of stored calcium ions ($Ca^{2+}$) into the cytosol. Since intracellular calcium is essential for excitation-contraction coupling, its reduction prevents muscle fiber contraction without affecting neuromuscular transmission or cardiac/smooth muscle (which utilize different RyR isoforms) [1]. **Analysis of Options:** * **Option A:** While dantrolene does reduce calcium levels in the sarcoplasm, it specifically inhibits the **release** from the SR, not "secretion" (a term usually reserved for glandular activity). * **Option C:** GABA is the primary inhibitory neurotransmitter in the CNS [1]. Drugs like benzodiazepines or baclofen act via GABA receptors, but dantrolene acts peripherally on the muscle itself [1]. * **Option D:** Inhibition of gamma motor neurons is the mechanism associated with centrally acting muscle relaxants (e.g., diazepam), not direct-acting agents like dantrolene. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Dantrolene is the life-saving treatment for **Malignant Hyperthermia** (often triggered by succinylcholine or halothane) and **Neuroleptic Malignant Syndrome (NMS)**. * **Other Uses:** Management of spasticity associated with Upper Motor Neuron lesions (e.g., Cerebral Palsy, Multiple Sclerosis). * **Side Effect:** The most significant adverse effect is **hepatotoxicity** (monitor liver function tests). * **Key Distinction:** Unlike non-depolarizing blockers (e.g., vecuronium), dantrolene does not act at the nicotinic acetylcholine receptor (nAChR).

Q: Which beta-blocker lacks local anesthetic (membrane stabilizing) effect?

Timolol. The **Membrane Stabilizing Activity (MSA)**, also known as a local anesthetic effect, refers to the ability of certain beta-blockers to inhibit the initiation and propagation of action potentials by blocking voltage-gated sodium channels [1]. This property is independent of beta-adrenoceptor blockade. **Why Timolol is the Correct Answer:** **Timolol** is a potent, non-selective beta-blocker that **lacks MSA**. Because it does not have a local anesthetic effect, it does not cause corneal anesthesia when applied topically. This makes it the drug of choice for the chronic treatment of **Glaucoma**, as it preserves the protective corneal reflex. **Analysis of Incorrect Options:** * **Propranolol:** This is the prototype non-selective beta-blocker and possesses the **highest degree of MSA** [1]. While this contributes to its anti-arrhythmic properties, it makes it unsuitable for ophthalmic use as it would numb the cornea. * **Pindolol:** A non-selective beta-blocker that possesses both MSA and **Intrinsic Sympathomimetic Activity (ISA)** [1]. * **Metoprolol:** A cardioselective ($\beta_1$) blocker that possesses **weak but present MSA** [1]. **NEET-PG High-Yield Pearls:** * **Beta-blockers with MSA:** Propranolol (Max), Acebutolol, Metoprolol, Pindolol, Labetalol. (Mnemonic: **P**alms **A**re **M**ostly **P**ink **L**ately). * **Beta-blockers without MSA:** Timolol, Atenolol, Sotalol, Nadolol. * **Clinical Significance:** Drugs with MSA are generally avoided in patients with cardiac conduction defects but are useful in preventing certain arrhythmias. * **Glaucoma Tip:** Timolol is preferred over Propranolol for the eye specifically because it lacks MSA.

Q: What effect do muscarinic cholinergic agonists have?

Activate inhibitory G-proteins (Gi). **Explanation:** Muscarinic cholinergic receptors (M1–M5) are G-protein coupled receptors (GPCRs). To understand the correct answer, we must categorize these receptors based on their signaling pathways: * **M1, M3, M5:** Coupled with **Gq** proteins. They activate Phospholipase C (PLC), leading to increased IP3/DAG and increased intracellular calcium. * **M2, M4:** Coupled with **Gi** (inhibitory) proteins. **Why Option B is Correct:** Muscarinic agonists (like Acetylcholine, Pilocarpine, or Bethanechol) act on M2 receptors (primarily in the heart) and M4 receptors. Activation of the **Gi protein** inhibits Adenylyl Cyclase, leading to a decrease in cAMP levels. In the heart, this results in the opening of K+ channels and hyperpolarization, causing bradycardia. Since "muscarinic agonists" encompass effects on all subtypes, activating Gi is a primary mechanism for the M2/M4 subset. **Why Other Options are Incorrect:** * **Options A, C, and D:** These describe the *inhibition* of the Gq pathway. In reality, muscarinic agonists (acting via M1, M3, M5) **increase** the activity of Phospholipase C, **increase** the production of IP3, and **increase** the release of intracellular calcium (leading to smooth muscle contraction and gland secretion). **High-Yield NEET-PG Pearls:** * **M2 Receptors:** Located in the SA and AV nodes; activation causes negative chronotropy and dromotropy. * **M3 Receptors:** Located in smooth muscles (bronchoconstriction, bladder contraction) and glands (sweating, salivation). They also cause vasodilation via **Nitric Oxide (NO)** release from vascular endothelium. * **Mnemonic:** "Q-I-Q-I-Q" for M1 through M5 (Gq, Gi, Gq, Gi, Gq).

Q: Mechanism of action of clonidine is mediated by which of the following receptors?

Alpha 2. **Explanation:** **Clonidine** is a centrally acting sympatholytic drug. Its primary mechanism of action is the **selective stimulation of presynaptic Alpha-2 ($\alpha_2$) receptors** in the nucleus tractus solitarius (NTS) of the medulla. 1. **Why Alpha-2 is correct:** $\alpha_2$ receptors are primarily inhibitory G-protein coupled receptors ($G_i$). When clonidine stimulates these receptors in the vasomotor center of the brain, it inhibits the release of norepinephrine. This leads to a decrease in sympathetic outflow from the CNS to the peripheral tissues, resulting in a reduction in blood pressure and heart rate. 2. **Why other options are incorrect:** * **Alpha-1 ($\alpha_1$):** These are excitatory receptors found on vascular smooth muscle. Stimulation causes vasoconstriction and increases blood pressure (e.g., Phenylephrine). * **Beta-1 ($\beta_1$):** Located mainly in the heart; stimulation increases heart rate and contractility (e.g., Dobutamine). * **Beta-2 ($\beta_2$):** Located in bronchial and vascular smooth muscle; stimulation causes bronchodilation and vasodilation (e.g., Salbutamol). **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Uses:** Hypertension (not first-line), opioid withdrawal, ADHD, and prophylaxis for migraine. * **Adverse Effects:** Sedation, mental depression, and significant **dry mouth (xerostomia)**. * **Rebound Hypertension:** Sudden withdrawal of clonidine can cause a hypertensive crisis due to a massive surge in catecholamines. * **Diagnostic Test:** The **Clonidine Suppression Test** is used to differentiate between essential hypertension and Pheochromocytoma (norepinephrine levels fail to drop in Pheochromocytoma).

Q: Tachyphylaxis is an adverse effect of which of the following medications?

Dipevifrine. **Explanation:** **Tachyphylaxis** refers to a rapid decrease in the response to a drug after repeated doses (acute tolerance). In ophthalmology, this phenomenon is most characteristically associated with **Adrenergic agonists**, specifically **Dipivefrine** and Epinephrine. **Why Dipivefrine is correct:** Dipivefrine is a prodrug of Epinephrine. It acts on $\alpha$ and $\beta$ receptors to increase uveoscleral outflow and decrease aqueous production. With chronic use, the adrenergic receptors undergo "downregulation" or desensitization, leading to a rapid loss of the intraocular pressure (IOP) lowering effect. Additionally, Dipivefrine is notorious for causing **Adrenochrome deposits** in the conjunctiva and nasolacrimal duct. **Why other options are incorrect:** * **Betaxolol:** A cardioselective $\beta_1$-blocker. While "long-term drift" (slow loss of efficacy over months/years) can occur with beta-blockers, they do not typically exhibit the rapid tachyphylaxis seen with adrenergics. * **Latanoprost:** A Prostaglandin analogue (PGF2$\alpha$). These are the first-line drugs for glaucoma and are preferred because they maintain stable efficacy over long periods without significant tachyphylaxis. * **Dorzolamide:** A topical Carbonic Anhydrase Inhibitor (CAI). Its effect remains relatively constant as long as the enzyme inhibition is maintained. **High-Yield Clinical Pearls for NEET-PG:** * **Dipivefrine** is more lipophilic than Epinephrine, allowing better corneal penetration and fewer systemic side effects. * **Apraclonidine** (an $\alpha_2$ agonist) also shows significant tachyphylaxis, which is why it is used for short-term prophylaxis (e.g., post-laser) rather than chronic glaucoma management. * **Brimonidine** (selective $\alpha_2$ agonist) is less likely to cause tachyphylaxis compared to Apraclonidine but is highly associated with **follicular conjunctivitis**.

Q: Which of the following neuromuscular blocking agents has the least effect on the cardiovascular system?

Atracurium. **Explanation:** The cardiovascular stability of a neuromuscular blocking agent (NMBA) depends on its tendency to cause histamine release or its interaction with autonomic receptors (muscarinic or nicotinic). **Why Atracurium is the correct answer:** Atracurium is a benzylisoquinolone derivative known for its **minimal cardiovascular effects** at therapeutic doses. While it can cause some histamine release at very high doses (leading to transient hypotension or flushing), it lacks significant vagolytic or sympathomimetic activity. Furthermore, its unique metabolism via **Hofmann elimination** (spontaneous non-enzymatic degradation) and ester hydrolysis makes it independent of renal or hepatic function, further contributing to its safe profile in diverse clinical scenarios. **Analysis of Incorrect Options:** * **Gallamine:** This is the most cardiotoxic among the options. It has potent **antimuscarinic (vagolytic)** properties, leading to significant tachycardia and hypertension. * **Pancuronium:** An aminosteroid NMBA that exhibits moderate **vagolytic activity** and stimulates the sympathetic nervous system by inhibiting norepinephrine reuptake. This frequently results in tachycardia and increased blood pressure. * **Tubocurarine:** The prototype NMBA, it is notorious for causing significant **histamine release** and **ganglionic blockade**, which often leads to profound hypotension and bronchospasm. **High-Yield Clinical Pearls for NEET-PG:** * **Vecuronium and Rocuronium:** These are even more cardiovascularly stable than Atracurium (virtually no histamine release). * **Hofmann Elimination:** Atracurium and Cisatracurium are the drugs of choice in **liver and kidney failure**. * **Laudanosine:** A metabolite of Atracurium that can cross the BBB and potentially cause seizures (though rare in clinical practice). * **Cisatracurium:** An isomer of atracurium that is more potent and causes **less histamine release** than atracurium.

Q: Which of the following antiglaucoma drugs can cause heterochromia iridis?

Latanoprost. **Latanoprost** is the correct answer. It is a **Prostaglandin F2α (PGF2α) analog**, which is currently the first-line treatment for Open-Angle Glaucoma. **Mechanism of Side Effect:**Latanoprost causes **heterochromia iridis** (specifically, increased brown pigmentation of the iris) by stimulating the proliferation and activity of melanocytes in the iris stroma [1]. This leads to increased melanin content. This change is often permanent. Other characteristic side effects of prostaglandin analogs include **hypertrichosis** (increased eyelash growth/thickness) and **periorbital fat atrophy).**Analysis of Incorrect Options:** * **A. Timolol:** A non-selective beta-blocker. It reduces aqueous humor production. Its primary side effects are local (stinging) and systemic (bradycardia, bronchospasm in asthmatics), but it does not affect iris color. * **C. Apraclonidine:** An alpha-2 agonist. It reduces aqueous production and increases uveoscleral outflow. Common side effects include lid retraction and local allergic reactions (blepharoconjunctivitis). * **D. Acetazolamide:** A carbonic anhydrase inhibitor. It reduces aqueous humor formation. Systemic side effects include paresthesia, metabolic acidosis, and hypokalemia. **High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Prostaglandin analogs (Latanoprost, Bimatoprost, Travoprost) lower IOP by increasing **uveoscleral outflow**. * **Bimatoprost** is specifically FDA-approved for the treatment of eyelash hypotrichosis. * **Contraindication:** Prostaglandin analogs should be avoided in **uveitic glaucoma** as they may exacerbate intraocular inflammation (cystoid macular edema).

Question 1

What is the mechanism of action of dantrolene?

Accepted Answer

Binds to ryanodine receptors to block the release of Ca++

Answer

Inhibits Ca++ secretion from sarcoplasm

Answer

Inhibits GABA

Answer

Inhibits the gamma motor neuron

Question 2

Which beta-blocker lacks local anesthetic (membrane stabilizing) effect?

Accepted Answer

Timolol

Answer

Metoprolol

Answer

Pindolol

Answer

Propranolol

Question 3

What effect do muscarinic cholinergic agonists have?

Accepted Answer

Activate inhibitory G-proteins (Gi)

Answer

Decrease production of IP3

Answer

Decrease release of intracellular calcium

Answer

Inhibit the activity of phospholipase C

Question 4

Mechanism of action of clonidine is mediated by which of the following receptors?

Accepted Answer

Alpha 2

Answer

Alpha 1

Answer

Beta 1

Answer

Beta 2

Question 5

Tachyphylaxis is an adverse effect of which of the following medications?

Accepted Answer

Dipevifrine

Answer

Betaxalol

Answer

Latanoprost

Answer

Dorzolamide

Question 6

Which antihistamine is used in motion sickness?

Accepted Answer

Diphenhydramine

Answer

Cetirizine

Answer

Meclizine

Answer

Fexofenadine

Question 7

Which of the following neuromuscular blocking agents has the least effect on the cardiovascular system?

Accepted Answer

Atracurium

Answer

Gallamine

Answer

Pancuronium

Answer

Tubocurarine

Question 8

Which of the following statements regarding adrenergic receptors is NOT true?

Accepted Answer

Alpha-1 receptors are usually postsynaptic

Answer

Beta-1 receptors are predominantly found in the heart

Answer

Noradrenaline stimulates beta-1 receptors

Answer

Alpha-2 receptor stimulation inhibits transmitter release

Question 9

Which of the following antiglaucoma drugs can cause heterochromia iridis?

Accepted Answer

Latanoprost

Answer

Timolol

Answer

Apraclonidine

Answer

Acetazolamide

Question 10

The beneficial effect of neostigmine in the treatment of Myasthenia gravis is due to which action?

Accepted Answer

It inhibits the action of cholinesterase

Answer

It produces more acetylcholine

Answer

It produces more acetylcholine receptors

Answer

It increases the action of cholinesterase

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?